搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 24 小时
时间不限
过去 1 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
13 小时
Fox Chase Cancer Center oncologist talks personalized medicine for pancreatic cancer
There's no routine screening test for pancreatic cancer, and symptoms can be mistaken for common illnesses.
21 小时
NovoCure: PANOVA-3 Data Suggests A Potential Game-Changer For Pancreatic Cancer
NovoCure's TTFields therapy, combined with standard chemotherapy, improves overall survival in advanced pancreatic cancer.
14 小时
Novocure Has Already Doubled in 2024. Can It Soar Higher in 2025?
The life science industry recently gave folks diagnosed with pancreatic cancer the best news this group has received in a ...
health.economictimes.indiatimes
22 小时
US FDA approves Merus' therapy to treat lung, pancreatic cancers
The therapy, branded as Bizengri, targets the NRG1 gene, which is associated with formation and progression of several tumors ...
10 小时
Theriva™ Biologics Announces U.S. FDA Guidance on Design of Phase 3 Study of VCN-01 for ...
Theriva™ (NYSE American: TOVX), a diversified clinical-stage company developing therapeutics designed to treat cancer and ...
3 小时
on MSN
Common vitamin could double life expectancy for pancreatic cancer patients
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Becker's Hospital Review
53 分钟
FDA approves therapy to treat lung, pancreatic cancers
The FDA approved a new cancer treatment called Bizengri for adults with certain types of lung and pancreatic cancers. The approval is the first for a treatment designed for cancers with an NRG1 gene ...
20 小时
on MSN
US drug body approves Merus' therapy for lung, pancreatic cancer patients
The therapy, branded as Bizengri, targets the NRG1 gene, which is associated with formation and progression of several tumors ...
MedPage Today
1 小时
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
In a new survey, radiation oncologists blamed prior authorization delays for multiple harms to patients, including ...
10 小时
RenovoRx Receives First Purchase Orders for its FDA-Cleared RenovoCath® Delivery System
Over Ten Medical Institutions Nationwide have Initiated RenovoCath Purchase Process,Further Accelerating Commercialization ...
12 小时
on MSN
Formaldehyde causes more cancer than any other toxic air pollutant. Little is being done to ...
In a world flush with hazardous air pollutants, there is one that causes far more cancer than any other, one that is so ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈